跳至主要内容
临床试验/NCT02075554
NCT02075554已完成不适用

Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach

Globus Medical Inc4 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2012年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
58
试验地点
4
主要终点
Fusion Assessment

研究概览

简要总结

The primary objective of this study is to evaluate the safety and efficacy of CALIBER expandable spacer for the treatment of degenerative disc disease. Radiographic outcomes, intra-operative parameters, clinical outcomes, and patient satisfaction will be obtained from patients in this 2 year follow-up clinical study.

详细描述

Patients will be followed-up at 3weeks, 6 weeks, 3 months, 6 months, 12 and 24 months with X-rays and questionnaires to determine their satisfaction, healing, fusion and return to work status

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DDD at 1 or 2 levels between L2 and S1
  • Between 18 and 80 years of age
  • Unresponsiveness to documented non-surgical treatment modalities for a minimum of six months
  • Ability to provide a signed Informed Consent

排除标准

  • Trauma at level(s) to be fused
  • Previous documentation of osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
  • Immunosuppressive disorder
  • History of substance abuse
  • Any known allergy to a metal alloy

结局指标

主要结局

Fusion Assessment

时间窗: 24 months

An assessment of the fusion status of surgically treated spinal levels.

Fusion and Disc Height Maintenance

时间窗: 24 months

Inter-vertebral disc height in millimetres at 24 month follow up.

次要结局

  • Patient Self Assessment(Upto 24 mo)
  • Visual Analog Scale for Back Pain(24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Study of an Expandable Interbody Device for the... | 临床试验